Skip to main content
Log in

Upregulation of Ghrelin Gene Expression in the Excluded Stomach of Obese Women with Type 2 Diabetes After Roux-en-Y Gastric Bypass in the SURMetaGIT Study

  • Brief Communication
  • Published:
Obesity Surgery Aims and scope Submit manuscript

Abstract

Background

Mechanisms of type 2 diabetes remission (T2Dr) after Roux-en-Y gastric bypass (RYGB) in obese patients appear to involve gastrointestinal hormones.

Objective

The objective of this study is to explore changes in ghrelin plasma levels and ghrelin gastrointestinal gene expression (GHRL) after RYGB, and their relationships to T2Dr.

Setting

In 20 obese women with T2D, before and 3 months after RYGB, we assessed GHRL expression by microarray and quantitative RT-PCR in gastrointestinal biopsy samples and plasma levels of ghrelin.

Results

After RYGB, GHRL expression increased in the excluded stomach (p < 0.05) with no change in other gastrointestinal sites. There were no significant changes in ghrelin plasma levels and no correlations with T2Dr.

Conclusions

After RYGB, over-expression of GHRL gene occurs only in the excluded stomach with no correlation to T2Dr.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Abbreviations

GIT:

Gastrointestinal tract

GLP-1:

Glucagon-like peptide-1

GHRL:

Ghrelin gene

HC-FMUSP:

Hospital das Clinicas, Faculdade de Medicina da Universidade de Sao Paulo

RYGB:

Roux-en-Y gastric bypass

T2D:

Type 2 diabetes

T2Dr:

Type 2 diabetes remission

BMI:

Body mass index

References

  1. Cummings DE, Arterburn DE, Westbrook EO, et al. Gastric bypass surgery vs intensive lifestyle and medical intervention for type 2 diabetes: the CROSSROADS randomized controlled trial. Diabetologia. 2016;59(5):945–53. https://doi.org/10.1007/s00125-016-3903-x.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Sala PC, Torrinhas RS, Giannella-Neto D, et al. Relationship between gut hormones and glucose homeostasis after bariatric surgery. Diabetol Metab Syndr. 2014;6(1):87. https://doi.org/10.1186/1758-5996-6-87.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Cohen RV, Rubino F, Schiavon C, et al. Diabetes remission without weight loss after duodenal bypass surgery. Surg Obes Relat Dis. 2012;8(5):e66–8. https://doi.org/10.1016/j.soard.2011.07.007.

    Article  PubMed  Google Scholar 

  4. Gagnon J, Baggio LL, Drucker DJ, et al. Ghrelin is a novel regulator of GLP-1 secretion. Diabetes. 2015;64(5):1513–21. https://doi.org/10.2337/db14-1176.

    Article  CAS  PubMed  Google Scholar 

  5. Steinert RE, Feinle-Bisset C, Asarian L, et al. Ghrelin, CCK, GLP-1, and PYY(3-36): Secretory controls and physiological roles in eating and glycemia in health, obesity, and after RYGB. Physiol Rev. 2017;97(1):411–63. https://doi.org/10.1152/physrev.00031.2014.

    Article  PubMed  Google Scholar 

  6. Rhee NA, Wahlgren CD, Pedersen J, et al. Effect of Roux-en-Y gastric bypass on the distribution and hormone expression of small-intestinal enteroendocrine cells in obese patients with type 2 diabetes. Diabetologia. 2015;58(10):2254–8. https://doi.org/10.1007/s00125-015-3696-3.

    Article  CAS  PubMed  Google Scholar 

  7. Sala P, Belarmino G, Machado NM, et al. The SURMetaGIT study: design and rationale for a prospective pan-omics examination of the gastrointestinal response to Roux-en-Y gastric bypass surgery. J Int Med Res. 2016;44(6):1359–75. https://doi.org/10.1177/0300060516667862.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Sala P, Torrinhas RS, Fonseca DC, et al. Type 2 diabetes remission after Roux-en-Y gastric bypass: Evidence for increased expression of jejunal genes encoding regenerating pancreatic islet-derived proteins as a potential mechanism. Obes Surg. 2017;27(4):1123–7. https://doi.org/10.1007/s11695-017-2602-0.

    Article  PubMed  Google Scholar 

  9. Breitling R, Armengaud P, Amtmann A, et al. Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments. FEBS Lett. 2004;573(1-3):83–92. https://doi.org/10.1016/j.febslet.2004.07.055.

    Article  CAS  PubMed  Google Scholar 

  10. John B. Buse, Sonia Caprio, William T. Cefalu, Antonio Ceriello, Stefano Del Prato, Silvio E. Inzucchi, et al. How do we define cure of diabetes? Diabetes Care 2009;32:2133–2135;

  11. Korner J, Bessler M, Inabnet W, et al. Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding. Surg Obes Relat Dis. 2007;3(6):597–601. https://doi.org/10.1016/j.soard.2007.08.004.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Holdstock C, Zethelius B, Sundbom M, et al. Postprandial changes in gut regulatory peptides in gastric bypass patients. Int J Obes. 2008;32(11):1640–6. https://doi.org/10.1038/ijo.2008.157.

    Article  CAS  Google Scholar 

  13. Korner J, Inabnet W, Conwell IM, et al. Differential effects of gastric bypass and banding on circulating gut hormone and leptin levels. Obesity (Silver Spring). 2006;14(9):1553–61. https://doi.org/10.1038/oby.2006.179.

    Article  CAS  Google Scholar 

  14. Morey JS, Ryan JC, Van Dolah FM. Microarray validation: factors influencing correlation between oligonucleotide microarrays and real-time PCR. Biol Proced Online. n8:175–93.

Download references

Acknowledgements

We thank Daniele Yumi for the statistical discussion of the data and the late Prof Daniel Giannella Neto who had an important role and participated in this study.

Funding

This study was funded by Fundação de Amparo à Pesquisa do Estado de São Paulo (Fapesp) project (no. 2011/09612–3) and scholarship DD (2013/03246-0) and by the CAPES scholarship.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Danielle Cristina Fonseca.

Ethics declarations

This study was performed according to the Declaration of Helsinki and the protocol was approved by the local ethics committee (CAPPesq 1011/09) and registered at www.ClinicalTrials.gov (NCT01251016). Written informed consent was obtained from all patients.

Conflicts of Interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fonseca, D.C., Sala, P., Singer, J. et al. Upregulation of Ghrelin Gene Expression in the Excluded Stomach of Obese Women with Type 2 Diabetes After Roux-en-Y Gastric Bypass in the SURMetaGIT Study. OBES SURG 28, 877–880 (2018). https://doi.org/10.1007/s11695-017-3098-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-017-3098-3

Keywords

Navigation